title: Multiple sclerosis: Dimethyl fumarate is coming of age.
authors.affiliation: Centre d'Esclerosi Múltiple de Catalunya, Department of Neurology/Neuroimmunology, Hospital Universitari Vall d'Hebron, Passeig Vall d'Hebron 119-129, Universitat Autònoma de Barcelona, Barcelona 08035, Spain.
authors.forename: Mar
authors.initials: M
authors.lastname: Tintoré
authors.affiliation: Centre d'Esclerosi Múltiple de Catalunya, Department of Neurology/Neuroimmunology, Hospital Universitari Vall d'Hebron, Passeig Vall d'Hebron 119-129, Universitat Autònoma de Barcelona, Barcelona 08035, Spain.
authors.forename: Jaume
authors.initials: J
authors.lastname: Sastre-Garriga
mesh_terms: D000069462:Dimethyl Fumarate / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000000981:diagnostic imaging* / Q000188:drug therapy* / Q000276:immunology; D016032:Randomized Controlled Trials as Topic / Q000379:methods
chemical_list: D007166:Immunosuppressive Agents; D000069462:Dimethyl Fumarate